Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy OptimizeRx Corporation stock

Own OptimizeRx Corporation stock in just a few minutes.

Fact checked

OptimizeRx Corporation is a health information services business based in the US. OptimizeRx Corporation shares (OPRX) are listed on the NASDAQ and all prices are listed in US Dollars. OptimizeRx Corporation employs 70 staff and has a trailing 12-month revenue of around USD$34.3 million.

How to buy shares in OptimizeRx Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for OptimizeRx Corporation. Find the stock by name or ticker symbol: OPRX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OptimizeRx Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of OptimizeRx Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of OptimizeRx Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

OptimizeRx Corporation share price

Use our graph to track the performance of OPRX stocks over time.

OptimizeRx Corporation shares at a glance

Information last updated 2021-02-24.
52-week rangeUSD$6.5019 - USD$63.98
50-day moving average USD$47.3673
200-day moving average USD$28.6406
Wall St. target priceUSD$61.33
PE ratio 247.0732
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.041

Buy OptimizeRx Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OptimizeRx Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is OptimizeRx Corporation under- or over-valued?

Valuing OptimizeRx Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OptimizeRx Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

OptimizeRx Corporation's P/E ratio

OptimizeRx Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 247x. In other words, OptimizeRx Corporation shares trade at around 247x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

OptimizeRx Corporation's PEG ratio

OptimizeRx Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1267. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into OptimizeRx Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

OptimizeRx Corporation's EBITDA

OptimizeRx Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$298,779.

The EBITDA is a measure of a OptimizeRx Corporation's overall financial performance and is widely used to measure a its profitability.

OptimizeRx Corporation financials

Revenue TTM USD$34.3 million
Gross profit TTM USD$15.4 million
Return on assets TTM -5.18%
Return on equity TTM -12.64%
Profit margin -16.19%
Book value $3.097
Market capitalisation USD$924.6 million

TTM: trailing 12 months

Shorting OptimizeRx Corporation shares

There are currently 1.0 million OptimizeRx Corporation shares held short by investors – that's known as OptimizeRx Corporation's "short interest". This figure is 4.1% up from 988,890 last month.

There are a few different ways that this level of interest in shorting OptimizeRx Corporation shares can be evaluated.

OptimizeRx Corporation's "short interest ratio" (SIR)

OptimizeRx Corporation's "short interest ratio" (SIR) is the quantity of OptimizeRx Corporation shares currently shorted divided by the average quantity of OptimizeRx Corporation shares traded daily (recently around 189255.88235294). OptimizeRx Corporation's SIR currently stands at 5.44. In other words for every 100,000 OptimizeRx Corporation shares traded daily on the market, roughly 5440 shares are currently held short.

However OptimizeRx Corporation's short interest can also be evaluated against the total number of OptimizeRx Corporation shares, or, against the total number of tradable OptimizeRx Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OptimizeRx Corporation's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 OptimizeRx Corporation shares in existence, roughly 70 shares are currently held short) or 0.0706% of the tradable shares (for every 100,000 tradable OptimizeRx Corporation shares, roughly 71 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against OptimizeRx Corporation.

Find out more about how you can short OptimizeRx Corporation stock.

OptimizeRx Corporation share dividends

We're not expecting OptimizeRx Corporation to pay a dividend over the next 12 months.

Have OptimizeRx Corporation's shares ever split?

OptimizeRx Corporation's shares were split on a 1:3 basis on 14 May 2018. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OptimizeRx Corporation shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for OptimizeRx Corporation shares which in turn could have impacted OptimizeRx Corporation's share price.

OptimizeRx Corporation share price volatility

Over the last 12 months, OptimizeRx Corporation's shares have ranged in value from as little as $6.5019 up to $63.98. A popular way to gauge a stock's volatility is its "beta".

OPRX.US volatility(beta: 0.64)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OptimizeRx Corporation's is 0.6435. This would suggest that OptimizeRx Corporation's shares are less volatile than average (for this exchange).

OptimizeRx Corporation overview

OptimizeRx Corporation operates as a digital health company that facilitates communication at point-of-care among various stakeholders in healthcare. Its cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, and critical clinical information; and network consists of electronic health record company platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and clinical messaging services. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site